Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





PHENYL MERCAPTAN								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 108-98-5; **Chemical Formula:** C6H5SH
OSHA previously had no exposure limit for phenyl mercaptan. The ACGIH has a TLV-TWA of 0.5 ppm. NIOSH recommends a 15-minute ceiling limit of 0.1 ppm for phenyl mercaptan (benzenethiol). The Agency proposed a permissible exposure limit of 0.5 ppm as an 8-hour TWA, and the final rule establishes this limit. Phenyl mercaptan is a colorless liquid with an offensive, garlic-like odor.
The primary acute hazards of exposure to phenyl mercaptan are central nervous system stimulation followed by post-convulsive CNS depression, severe eye and skin irritation, systemic toxicity to spleen, kidney, lung, and liver tissues, and narcotic effects (ACGIH 1986/Ex. 1-3, p. 478).
Phenyl mercaptan has been reported to have 4-hour inhalation LC(50) values of 33 and 28 ppm for rats and mice, respectively (Doull and Plzak 1962, as cited in ACGIH 1986/Ex. 1-3, p. 478; Fairchild and Stokinger 1958/Ex. 1-415). The oral LD(50) for the rat is reported to be 46 mg/kg (McCord and Witheridge 1949/Ex. 1-882; Robles 1975, as cited in ACGIH 1986/Ex. 1-3, p. 478). For the rabbit and rat, the dermal LD(50) values are 134 mg/kg and 300 mg/kg, respectively (Doull and Plzak 1962, as cited in ACGIH 1986/Ex. 1-3, p. 478; Fairchild and Stokinger 1958/Ex. 1-415); Schafer 1972/Ex. 1-362). The responses of animals to phenyl mercaptan exposure were uniform regardless of species, and progressed from CNS stimulation to incoordination, skeletal and muscular paralysis, and respiratory depression, followed at high concentrations by coma and death. High doses (not further specified) administered via inhalation produced lung, liver, and kidney changes in mice (Doull and Plzak 1962, as cited in ACGIH 1986/Ex. 1-3, p. 478; Fairchild and Stokinger 1958/ Ex. 1-415); Schafer 1972/Ex. 1-362). In rabbits, phenyl mercaptan is a severe eye and skin irritant (McCord and Witheridge 1949/Ex. 1-882; Robles 1975, as cited in ACGIH 1986/ Ex. 1-3, p. 478; Schafer 1972/Ex. 1-362).
In humans, phenyl mercaptan is a moderately toxic skin irritant and causes severe dermatitis, headaches, and dizziness at unspecified levels (Fairchild and Stokinger 1958/Ex. 1-415; McCord and Witheridge 1949/Ex. 1-882). NIOSH (Ex. 8-47, Table N7; Tr. p. 3-99) believes that the limit for phenyl mercaptan is better expressed as a ceiling than as a time-weighted average; however, OSHA believes that a TWA limit set at 0.5 ppm will protect against phenyl mercaptan’s toxic effects. No other comments on the health effects of phenyl mercaptan were submitted to the rulemaking record.
OSHA is establishing an 8-hour TWA limit of 0.5 ppm for phenyl mercaptan. The Agency concludes that this limit will protect workers from the significant risks of CNS effects, skin irritation, and systemic injury, all material impairments of health that are potentially associated with exposure to phenyl mercaptan at the uncontrolled levels formerly permitted by the absence of any OSHA limit.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue